SCHEMBL23217897

SCHEMBL23217897

Cc1cccc(C(=O)C(=O)c2ccc3ncc(C(O)CNC(=O)OC(C)(C)C)nc3c2)n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.34
PDPK1 O15530 1/20 0.33
NAMPT P43490 4/20 0.33
LATS1 O95835 4/20 0.33
LCK P06239 1/20 0.33
RAB9A P51151 1/20 0.33
GABRA5 P31644 1/20 0.33
LATS2 Q9NRM7 1/20 0.33
ACACB O00763 1/20 0.32
ACACA Q13085 1/20 0.32
PCSK9 Q8NBP7 1/20 0.32
CKS1B P61024 1/20 0.32
SKP1 P63208 1/20 0.32
SKP2 Q13309 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
P2RX7 Q99572 1/20 0.32
TGFBR1 P36897 1/20 0.32
BRD4 O60885 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23217952 0.85 TGFBR1 (0.33) PDPK1NAMPTPCSK9CKS1BSKP1
SCHEMBL23217900 0.81 GABRA5 (0.38) NPC1NAMPTLATS1GABRA5CKS1B
SCHEMBL23217910 0.76 CA12 (0.40) LATS1GABRA5CKS1BSKP1SKP2
SCHEMBL8293584 0.75 PCSK9 (0.42) ACACBACACAPCSK9GAAP2RX7
SCHEMBL23217942 0.75 TGFBR1 (0.47) PDPK1ACACBACACATGFBR1
SCHEMBL23217923 0.71 NPC1 (0.40) NPC1RAB9AKDM4EALDH1A1GAA
SCHEMBL4858870 0.69 NPC1 (0.60) NPC1RAB9AKDM4EALDH1A1GAA
SCHEMBL24214779 0.69 STK17B (0.37) NAMPTLATS1LATS2PCSK9CKS1B
SCHEMBL4920111 0.68 PCSK9 (0.40) PCSK9CKS1BSKP1SKP2KDM4E
SCHEMBL4916056 0.67 HCAR3 (0.42) NAMPTGABRA5GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022006340-A1 ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2022-01-06 WO disclosed
WO-2021072330-A1 GALNAC-TGFBR1 INHIBITOR CONJUGATES FOR THE TREATMENT OF LIVER DISEASES SILVERBACK THERAPEUTICS, INC. (US) 2021-04-15 WO disclosed